Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman

Jyoti Burad; Sonali Kodange

doi:10.5005/jp-journals-10071-23959

SEARCH WITHIN CONTENT

Online First

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman

Jyoti Burad, Sonali Kodange

Citation Information : Burad J, Kodange S. Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman. Indian J Crit Care Med 2021; 25 (9):1073-1074.

DOI: 10.5005/jp-journals-10071-23959

License: CC BY-NC 4.0

Published Online: 08-09-2021

ARTICLE
REFERENCES

Abstract

HTML PDF Share

Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142(10):1137–1145. DOI: 10.1176/ajp.142.10.1137. PMID: 2863986.
Tse L, Barr AM, Scarapicchia V, Vila-Rodriguez F. Neuroleptic malignant syndrome: a review from a clinically oriented perspective. Curr Neuropharmacol 2015;13(3):395–406. DOI: 10.2174/1570159x13999150424113345. PMID: 26411967; PMCID: PMC4812801.
Page V. Sedation in mechanically ventilated patients with COVID- 19. Lancet Respir Med 2021;9(3):218–219. DOI: 10.1016/S2213-2600(20)30570-1.
Tsai JH, Yang P, Yen JY, Chen CC, Yang MJ. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. Pharmacotherapy 2005;25(8):1156–1159. DOI: 10.1592/phco.2005.25.8.1156. PMID: 162071.
Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164(6):870–876. DOI: 10.1176/ajp.2007.164.6.870. PMID: 17541044.

PDF Share